A carregar...

Design of thienopyranone-based BET inhibitors that bind multiple synthetic lethality targets

Development of small molecule compounds that target several cancer drivers has shown great therapeutic potential. Here, we developed a new generation of highly potent thienopyranone (TP)-based inhibitors for the BET bromodomains (BDs) of the transcriptional regulator BRD4 that have the ability to si...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Sci Rep
Main Authors: Vann, Kendra R., Pal, Dhananjaya, Morales, Guillermo A., Burgoyne, Adam M., Durden, Donald L., Kutateladze, Tatiana G.
Formato: Artigo
Idioma:Inglês
Publicado em: Nature Publishing Group UK 2020
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7374098/
https://ncbi.nlm.nih.gov/pubmed/32694708
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41598-020-68964-6
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!